Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2009
11/17/2009US7618955 Association of an antithrombotic and aspirin
11/17/2009US7618818 Method for detecting leptin receptor ligands
11/17/2009US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009CA2399299C Compounds with chelation affinity and selectivity for first transition series elements and their use
11/17/2009CA2397450C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
11/17/2009CA2397244C Ace inhibitor-vasopressin antagonist combinations
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2369997C Compositions and methods for treating amyloidosis
11/17/2009CA2336822C Method of treatment and pharmaceutical composition
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/17/2009CA2206794C Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
11/12/2009WO2009137681A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009WO2009137510A2 Method for protecting humans against superficial vasodilator flush syndrome
11/12/2009WO2009137342A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-i j ] quinoline compounds
11/12/2009WO2009137334A2 Method for treating neurodegenerative dysfunction
11/12/2009WO2009137201A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136814A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136813A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases
11/12/2009WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135590A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009WO2009135581A2 Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/12/2009WO2009135423A1 Pharmceuttical composition for treating cardio-cerebro vascular diseases and preparative method and kit thereof
11/12/2009WO2009135352A1 A plum tree extract, a method for preparing the plum tree extract and use thereof
11/12/2009WO2009135299A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/12/2009WO2009115906A3 A process for the preparation of carvedilol involving halohydrin derivative
11/12/2009WO2009071691A3 Oxindole derivatives and the use thereof as a medication
11/12/2009WO2009070241A3 Angiotensin ii receptor antagonists
11/12/2009WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033767A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009WO2009018807A9 Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy
11/12/2009WO2009012901A3 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
11/12/2009US20090281188 treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata or secondary acne with adapalene; sunscreen agents; antiproliferative agents
11/12/2009US20090281183 L-carnitine calcium fumarate, preparation method and application for the same
11/12/2009US20090281167 Compositions and methods related to mirna modulation of neovascularization or angiogenesis
11/12/2009US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009US20090281136 Prasugrel pharmaceutical formulations
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009US20090281103 Renin Inhibitors
11/12/2009US20090281092 Polo-like kinase inhibitors
11/12/2009US20090281087 Compounds II
11/12/2009US20090281086 2 -oxyheteroarylamide derivatives as parp inhibitors
11/12/2009US20090281083 Combination Product
11/12/2009US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009US20090281077 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
11/12/2009US20090281071 Therapeutic agent for hypertension
11/12/2009US20090281067 Nitroxyl progenitor compounds and methods of use
11/12/2009US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009US20090281062 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/12/2009US20090281061 Impaired Alleles of Genes Involved in Metabolic Pathways and Methods for Detecting and Using the Same
11/12/2009US20090281052 Indole Antiviral Compositions And Methods
11/12/2009US20090281019 Compositions and methods for treating atrial fibrillation
11/12/2009US20090280172 Galenic formulations of organic compounds
11/12/2009US20090280127 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-i
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723798A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009CA2723775A1 Therapeutically useful substituted 1,7-diphenyl-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline compounds
11/12/2009CA2723688A1 Method for treating neurodegenerative dysfunction
11/12/2009CA2723302A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009CA2722734A1 3,4-substituted piperidine derivatives as renin inhibitors
11/12/2009CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009CA2719288A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/11/2009EP2116250A1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
11/11/2009EP2116242A1 New pharmaceutical composition
11/11/2009EP2114922A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator
11/11/2009EP2114920A1 Substituted isoquinoline and isoquinolinone derivatives
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP2114881A1 Process for the purification of carvedilol or its salts thereof
11/11/2009EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof
11/11/2009EP2114427A1 Peptides for treatment of conditions associated with nitric oxide
11/11/2009EP2114417A1 New use of nitrites and nitrates and compositions containing these
11/11/2009EP2114411A2 Composition and method for protecting mitochondria
11/11/2009EP2114156A1 Chemical compounds, pharmaceutical compositions and methods
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1818052B1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others
11/11/2009EP1669462B1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product
11/11/2009EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009EP1557407B1 Novel alpha-ketoamide derivatives and use thereof
11/11/2009EP1490120B1 Embolization
11/11/2009EP1482795B1 New immunoeffector compounds
11/11/2009EP1427418B1 Piperazinone compounds as anti-tumor and anti-cancer agents
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
1 ... 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 ... 1595